ProMIS Neurosciences Announces First Quarter 2022 Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States ,United Kingdom ,Massachusetts ,Saskatchewan ,Manitoba ,Canada ,Montreal ,Quebec ,Cambridge ,Cambridgeshire ,Toronto ,Ontario ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,American ,British ,Larry Altstiel ,Carsten Korth ,Nicholas Rigopulos ,Alain Dagher ,Neil Cashman ,Gene Williams ,David Wishart ,Guy Rouleau ,Justin Yerbury ,Michelle Hastings ,University Of Saskatchewan Vaccine ,Department Of Neurology ,Linkedin ,Twitter ,Good Laboratory Practice ,Tanenbaum Open Science Institute ,Pfizer ,Neurosurgery Of Mcgill University ,University Of California San Diego ,University Of British Columbia ,Laboratory Medicine ,Neuro Montreal Neurological Institute ,Promis Neurosciences Inc ,Toronto Stock Exchange ,Infectious Disease Organization ,American Academy Of Neurology ,Chief Medical Officer ,Potential Next Generation Therapy ,Good Manufacturing Practice ,British Columbia ,Gene Yeo ,California San Diego ,American Academy ,Associated Global Translational Suppression ,Saskatchewan Vaccine ,Chief Physics Officer ,Scientific Advisory ,Molecular Neuropathology ,Cheryl Wellington ,Montreal Neurological Institute Hospital ,Mcgill University ,Mcgill University Health Centre ,Tanenbaum Open Science ,Montreal Neurological ,Chief Medical ,Months Ended March ,North American ,Collective Coordinates ,Disease Specific Epitopes ,Investor Relations ,Technology ,Health ,Globe Newswire ,Mental Health ,Clinical Trials ,Biotechnology ,Schizophrenia ,